Comerica Bank’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$22.5K Buy
2,169
+1,379
+175% +$14.5K ﹤0.01% 3061
2025
Q3
$6.99K Sell
790
-335
-30% -$2.39K ﹤0.01% 3338
2025
Q2
$6.49K Buy
1,125
+783
+229% +$4.8K ﹤0.01% 3317
2025
Q1
$2.26K Sell
342
-430
-56% -$3.35K ﹤0.01% 3458
2024
Q4
$6.72K Buy
772
+551
+249% +$7.93K ﹤0.01% 3249
2024
Q3
$4.32K Hold
221
﹤0.01% 3368
2024
Q2
$4.55K Hold
221
﹤0.01% 3322
2024
Q1
$4.71K Buy
221
+83
+60% +$1.61K ﹤0.01% 3351
2023
Q4
$1.99K Hold
138
﹤0.01% 3523
2023
Q3
$1.26K Buy
+138
New +$1.4K ﹤0.01% 3640

Other funds holding KURA

Comerica Bank's KURA Position: Q4 2025 in Review

Comerica Bank increased its Kura Oncology (KURA) stake by 175% in Q4 2025, buying an estimated $14.5K and bringing the position to 2,169 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3061.

Comerica Bank first reported a position in KURA in Q3 2023 and has held it in 10 quarters since. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Comerica Bank held 2,169 shares of Kura Oncology worth $22.5K as of Q4 2025.
  • Comerica Bank bought 1,379 Kura Oncology shares in Q4 2025, an estimated $14.5K.
  • Kura Oncology made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3061 holding.
  • Comerica Bank first reported a position in Kura Oncology in Q3 2023 and has held it in 10 quarters since.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.